Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HUMAN-MELANOMA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1628 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Huarte, E; Sarobe, P; Lasarte, JJ; Brem, G; Weiss, EH; Prieto, J; Borras-Cuesta, F
      Identification of HLA-B27-restricted cytotoxic T lymphocyte epitope from carcinoembryonic antigen

      INTERNATIONAL JOURNAL OF CANCER
    2. Ferroni, P; Di Filippo, F; Martini, F; Spila, A; D'Alessandro, R; Cavaliere, F; Anza, M; Garinei, R; Aloe, S; Carone, MD; Gazzaniga, PP; Guadagni, F
      Effects of isolated limb perfusion with tumor necrosis factor-alpha on circulating levels of proinflammatory cytokines

      JOURNAL OF IMMUNOTHERAPY
    3. Zeng, G
      MHC class II-restricted tumor antigens recognized by CD4(+) T cells: New strategies for cancer vaccine design

      JOURNAL OF IMMUNOTHERAPY
    4. Treon, SP; Mitsiades, C; Mitsiades, N; Young, G; Doss, D; Schlossman, R; Anderson, KC
      Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies

      JOURNAL OF IMMUNOTHERAPY
    5. Maliner-Stratton, MS; Klein, RD; Udayakumar, TS; Nagle, RB; Bowden, GT
      Interleukin-1 beta-induced promatrilysin expression is mediated by NF kappa B-regulated synthesis of interleukin-6 in the prostate carcinoma cell line, LNCaP

      NEOPLASIA
    6. Kim, SJ; Uehara, H; Karashima, T; Mccarty, M; Shih, N; Fidler, IJ
      Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice

      NEOPLASIA
    7. Wang, RF
      The role of MHC class II-restricted tumor antigens and CD4(+) T cells in antitumor immunity

      TRENDS IN IMMUNOLOGY
    8. Bodey, B
      Genetically engineered antibodies for direct antineoplastic treatment and systematic delivery of various therapeutic agents to cancer cells

      EXPERT OPINION ON BIOLOGICAL THERAPY
    9. Scanlan, MJ; Jager, D
      Challenges to the development of antigen-specific breast cancer vaccines

      BREAST CANCER RESEARCH
    10. Komba, S; Yamaguchi, M; Ishida, H; Kiso, M
      6-O-sulfo de-N-acetylsialyl Lewis X as a novel high-affinity ligand for human L-selectin: Total synthesis and structural characterization

      BIOLOGICAL CHEMISTRY
    11. Beck, A; Bussat, MC; Klinguer-Hamour, C; Goetsch, L; Aubry, JP; Champion, T; Julien, E; Haeuw, JF; Bonnefoy, JY; Corvaia, N
      Stability and CTL activity of N-terminal glutamic acid containing peptides

      JOURNAL OF PEPTIDE RESEARCH
    12. Albertini, MR; King, DM; Newton, MA; Vacek, PM
      In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood and lymph nodes of melanoma patients

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    13. Frank, S; Ebert, AD
      License to kill tumors: How much hope is justified for trail?

      CURRENT PHARMACEUTICAL DESIGN
    14. Lalla, RV; Goralnick, SJ; Tanzer, ML; Kreutzer, DL
      Fibrin induces IL-8 expression from human oral squamous cell carcinoma cells

      ORAL ONCOLOGY
    15. Neamati, N
      A small-molecule antagonist of virion assembly

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    16. Mitsiades, N; Mitsiades, CS; Poulaki, V; Anderson, KC; Treon, SP
      Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma andother neoplasias

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    17. Correale, P; Sabatino, M; Cusi, MG; Micheli, L; Nencini, C; Pozzessere, D; Petrioli, R; Aquino, A; De Vecchis, L; Turriziani, M; Prete, SP; Sanguedolce, R; Rausa, L; Giorgi, G; Francini, G
      In vitro generation of cytotoxic T lymphocytes against HLA-A2.1-restrictedpeptides derived from human thymidylate synthase

      JOURNAL OF CHEMOTHERAPY
    18. Schneider, GP; Salcedo, R; Welniak, LA; Howard, OMZ; Murphy, WJ
      The diverse role of chemokines in tumor progression: Prospects for intervention (Review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    19. Hernandez, A; Wang, QD; Schwartz, SA; Evers, BM
      Sensitization of human colon cancer cells to TRAIL-mediated apoptosis

      JOURNAL OF GASTROINTESTINAL SURGERY
    20. Sanderson, RD
      Heparan sulfate proteoglycans in invasion and metastasis

      SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
    21. Shi, Q; Xiong, QG; Le, XD; Xie, KP
      Regulation of interleukin-8 expression by tumor-associated stress factors

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    22. Kramer, G; Steiner, GE; Sokol, P; Handisurya, A; Klingler, HC; Maier, U; Foldy, M; Marberger, M
      Local intratumoral tumor necrosis factor-alpha and systemic IFN-alpha 2b in patients with locally advanced prostate cancer

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    23. Xiong, QH; Shi, Q; Le, XD; Wang, BL; Xie, KP
      Regulation of interleukin-8 expression by nitric oxide in human pancreaticadenocarcinoma

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    24. Smith, ES; Mandokhot, A; Evans, EE; Mueller, L; Borrello, MA; Sahasrabudhe, DM; Zauderer, M
      Lethality-based selection of recombinant genes in mammalian cells: Application to identifying tumor antigens

      NATURE MEDICINE
    25. Masood, R; Cai, J; Tulpule, A; Zheng, T; Hamilton, A; Sharma, S; Espina, BM; Smith, DL; Gill, PS
      Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma

      CLINICAL CANCER RESEARCH
    26. Bhoumik, A; Ivanov, V; Ronai, Z
      Activating transcription factor 2-derived peptides alter resistance of human tumor cell lines to ultraviolet irradiation and chemical treatment

      CLINICAL CANCER RESEARCH
    27. Porter, GA; Abdalla, J; Lu, MS; Smith, S; Montgomery, D; Grimm, E; Ross, MI; Mansfield, PF; Gershenwald, JE; Lee, JE
      Significance of plasma cytokine levels in melanoma patients with histologically negative sentinel lymph nodes

      ANNALS OF SURGICAL ONCOLOGY
    28. de Witte, H; van den Hurk, M; Sweep, F; Benraad, T; Geurts-Moespot, A; Ruiter, D; Verhofstad, A
      Development of quality control preparations for immunocytochemical assessment of urokinase-type plasminogen activator

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    29. Toschi, E; Barillari, G; Sgadari, C; Bacigalupo, I; Cereseto, A; Carlei, D; Palladino, C; Zietz, C; Leone, P; Sturzl, M; Butto, S; Cafaro, A; Monini, P; Ensoli, B
      Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor

      MOLECULAR BIOLOGY OF THE CELL
    30. Goodarzi, G; Mashimo, T; Watabe, M; Cuthbert, AP; Newbold, RF; Pai, SK; Hirota, S; Hosobe, S; Miura, K; Bandyopadhyay, S; Gross, SC; Balaji, KC; Watabe, K
      Identification of tumor metastasis suppressor region on the short arm of human chromosome 20

      GENES CHROMOSOMES & CANCER
    31. Yang, YM; Hatch, WC; Liu, ZY; Du, B; Groopman, JE
      beta-chemokine induction of activation protein-1 and cyclic AMP responsiveelement activation in human myeloid cells

      CELL GROWTH & DIFFERENTIATION
    32. Yang, FC; Merlino, G; Chin, L
      Genetic dissection of melanoma pathways in the mouse

      SEMINARS IN CANCER BIOLOGY
    33. Wittig, B; Marten, A; Dorbic, T; Weineck, S; Min, H; Niemitz, S; Trojaneck, B; Flieger, D; Kruopis, S; Albers, A; Loffel, J; Neubauer, A; Albers, P; Muller, S; Sauerbruch, T; Bieber, T; Huhn, D; Schmidt-Wolf, IGH
      Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: A first clinical phase I/II trial

      HUMAN GENE THERAPY
    34. Schraufstatter, IU; Chung, J; Burger, M
      IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways

      AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
    35. Inoue, K; Wood, CG; Slaton, JW; Karashima, T; Sweeney, P; Dinney, CPN
      Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8

      ONCOLOGY REPORTS
    36. Yutani, S; Shichijo, S; Inoue, Y; Kawagoe, N; Okuda, K; Kurohiji, T; Tanaka, M; Sata, M; Itoh, K
      Expression of the SART1 tumor-rejection antigen in hepatocellular carcinomas

      ONCOLOGY REPORTS
    37. Izawa, JI; Slaton, JW; Kedar, D; Karashima, T; Perrotte, P; Czerniak, B; Grossman, HB; Dinney, CPN
      Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder

      ONCOLOGY REPORTS
    38. Yu, YX; Heller, A; Liehr, T; Smith, CC; Aurelian, L
      Expression analysis and chromosome location of a novel gene (H11) associated with the growth of human melanoma cells

      INTERNATIONAL JOURNAL OF ONCOLOGY
    39. Akiba, J; Yano, H; Ogasawara, S; Higaki, K; Kojiro, M
      Expression and function of interleukin-8 in human hepatocellular carcinoma

      INTERNATIONAL JOURNAL OF ONCOLOGY
    40. Ahn, KS; Jung, YS; Kim, J; Lee, H; Yoon, SS
      Behavior of murine renal carcinoma cells crown in ectopic or orthotopic sites in syngeneic mice

      TUMOR BIOLOGY
    41. Rich, BE; Kupper, TS
      Cytokines: IL-20 - a new effector in skin inflammation

      CURRENT BIOLOGY
    42. Jager, E; Jager, D; Knuth, A
      Vaccines in breast cancer

      BREAST
    43. Kim, JY; Koo, HM; Kim, DSHL
      Development of C-20 modified betulinic acid derivatives as antitumor agents

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    44. Kageshita, T; Mizuno, M; Ono, T; Matsumoto, K; Saida, T; Yoshida, J
      Growth inhibition of human malignant melanoma transfected with the human interferon-beta gene by means of cationic liposomes

      MELANOMA RESEARCH
    45. Gunther, K; Fleischer, A; Buettner, R; Bosserhoff, AK
      Detection of invasion-related chromosomal changes in highly and weakly invasive melanoma cell clones by a modified comparative genomic hybridization approach

      MELANOMA RESEARCH
    46. Vuoristo, MS; Laine, S; Huhtala, H; Parvinen, LM; Hahka-Kemppinen, M; Korpela, M; Kumpulainen, E; Kellokumpu-Lehtinen, P
      Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma

      EUROPEAN JOURNAL OF CANCER
    47. Demeure, CE; Wolfers, J; Martin-Garcia, N; Gaulard, P; Triebel, F
      T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts

      EUROPEAN JOURNAL OF CANCER
    48. Van den Eynde, BJ; Morel, S
      Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome

      CURRENT OPINION IN IMMUNOLOGY
    49. Wang, TT; Fan, LQ; Watanabe, Y; McNeill, P; Fanger, GR; Persing, DH; Reed, SG
      L552S, an alternatively spliced isoform of XAGE-1, is over-expressed in lung adenocarcinoma

      ONCOGENE
    50. Knight, MJ; Riffkin, CD; Muscat, AM; Ashley, DM; Hawkins, CJ
      Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells

      ONCOGENE
    51. Maurici, D; Monti, P; Campomenosi, P; North, S; Frebourg, T; Fronza, G; Hainaut, P
      Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay

      ONCOGENE
    52. Gershenwald, JE; Sumner, W; Calderone, T; Wang, Z; Huang, SY; Bar-Eli, M
      Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo

      ONCOGENE
    53. Castro-Palomino, JC; Simon, B; Speer, O; Leist, M; Schmidt, RR
      Synthesis of ganglioside GD3 and its comparison with bovine GD3 with regard to oligodendrocyte apoptosis mitochondrial damage

      CHEMISTRY-A EUROPEAN JOURNAL
    54. Gaumann, A; Petrow, P; Mentzel, T; Mayer, E; Dahm, M; Otto, M; Kirkpatrick, CJ; Kriegsmann, J
      Osteopontin expression in primary sarcomas of the pulmonary artery

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    55. Nagashima, H; Sadanaga, N; Mashino, K; Yamashita, K; Inoue, H; Mori, M; Sugimachi, K
      Expression of MAGE-B genes in esophageal squamous cell carcinoma

      JAPANESE JOURNAL OF CANCER RESEARCH
    56. Toda, M; Iizuka, Y; Yu, W; Imai, T; Ikeda, E; Yoshida, K; Kawase, T; Kawakami, Y; Okano, H; Uyemura, K
      Expression of the neural RNA-binding protein musashi1 in human gliomas

      GLIA
    57. Meyskens, FL; Farmer, P; Fruehauf, JP
      Redox regulation in human melanocytes and melanoma

      PIGMENT CELL RESEARCH
    58. Bar-Eli, M
      Gene regulation in melanoma progression by the AP-2 transcription factor

      PIGMENT CELL RESEARCH
    59. Chambost, H; van Baren, N; Brasseur, F; Olive, D
      MAGE-A genes are not expressed in human leukemias

      LEUKEMIA
    60. Thomas, C; Yuki, N; Fertil, B
      Influence of gangliosides or LPS-like gangliosides on the tumoricidal activity of adherent leukocytes

      COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES
    61. Zaffaroni, N; Fiorentini, G; De Giorgi, U
      Hyperthermia and hypoxia: new developments in anticancer chemotherapy

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    62. Tsuda, N; Murayama, K; Ishida, H; Matsunaga, K; Komiya, S; Itoh, K; Yamada, A
      Expression of a newly defined tumor-rejection antigen SART3 in musculoskeletal tumors and induction of HLA class I-restricted cytotoxic T lymphocytesby SART3-derived peptides

      JOURNAL OF ORTHOPAEDIC RESEARCH
    63. Dias, S; Choy, M; Rafii, S
      The role of CXC chemokines in the regulation of tumor angiogenesis

      CANCER INVESTIGATION
    64. Kushner, BH; Kramer, K; Cheung, NKV
      Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma

      JOURNAL OF CLINICAL ONCOLOGY
    65. Baldi, A; Santini, D; Battista, T; Dragonetti, E; Ferranti, G; Petitti, T; Groeger, AM; Angelini, A; Rossiello, R; Baldi, F; Natali, PG; Paggi, MG
      Expression of AP-2 transcription factor and of its downstream target genesc-kit, E-cadherin and p21 in human cutaneous melanoma

      JOURNAL OF CELLULAR BIOCHEMISTRY
    66. Zambrano, A; Noli, C; Rauch, MC; Werner, E; Brito, M; Amthauer, R; Slebe, JC; Vera, JC; Concha, II
      Expression of GM-CSF receptors in male germ cells and their role in signaling for increased glucose and vitamin C transport

      JOURNAL OF CELLULAR BIOCHEMISTRY
    67. Chattopadhyay, N; Chatterjee, A
      Studies on the expression of alpha v beta 3 integrin receptors in non-malignant and malignant human cervical tumor tissues

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    68. Ristic-Fira, A; Nikolic, D; Petrovic, I; Ruzdijic, S; Raffaele, L; Sabini, MG; Cirrone, GAP; Cuttone, G; Farruggia, G; Masotti, L; Kanazir, DT
      The late effects of proton irradiation on cell growth, cell cycle arrest and apoptosis in a human melanoma cell line

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    69. Lara, PN; Gandara, DR; Longmate, J; Gumerlock, PH; Martin, DHML; Edelman, J; Gandour-Edwards, R; Mack, PC; Israel, V; Raschko, J; Frankel, P; Perez, EA; Lenz, HJ; Doroshow, JH
      Activity of high-dose toremifene plus cisplatin in platinum-treated nonsmall-cell lung cancer: a phase II California Cancer Consortium Trial

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    70. Thomas, C; Fertil, B
      Sensitivity of human melanoma cells to adherent leukocytes depends on the ratio between them, the activation status of adherent leukocytes and the metastatic potential of tumor cells

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    71. Renkvist, N; Castelli, C; Robbins, PF; Parmiani, G
      A listing of human tumor antigens recognized by T cells

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    72. Van Pel, A; De Plaen, E; Duffour, MT; Warnier, G; Uyttenhove, C; Perricaudet, M; Boon, T
      Induction of cytolytic T lymphocytes by immunization of mice with an adenovirus containing a mouse homolog of the human MAGE-A genes

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    73. Thomas, C; Buronfosse, A; Courdi, A; Fertil, B
      Radio-prevention of micrometastases

      MEDICAL HYPOTHESES
    74. Lin, HC; Morin, PJ
      A novel homozygous deletion at chromosomal band 6q27 in an ovarian cancer cell line delineates the position of a putative tumor suppressor gene

      CANCER LETTERS
    75. Nischt, R; Wallich, M; Reibetanz, M; Baumann, P; Krieg, T; Mauch, C
      BM-40 and MMP-2 expression are not coregulated in human melanoma cell lines

      CANCER LETTERS
    76. Varki, A
      N-glycolylneuraminic acid deficiency in humans

      BIOCHIMIE
    77. Malykh, YN; Schauer, R; Shaw, L
      N-glycolylneuraminic acid in human tumours

      BIOCHIMIE
    78. Woods, D; Cherwinski, H; Venetsanakos, E; Bhat, A; Gysin, S; Humbert, M; Bray, PF; Saylor, VL; McMahon, M
      Induction of beta 3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway

      MOLECULAR AND CELLULAR BIOLOGY
    79. Bardeesy, N; Bastian, BC; Hezel, A; Pinkel, D; DePinho, RA; Chin, L
      Dual inactivation of RB and p53 pathways in RAS-induced melanomas

      MOLECULAR AND CELLULAR BIOLOGY
    80. Nyormoi, O; Wang, Z; Doan, D; Ruiz, M; McConkey, D; Bar-Eli, M
      Transcription factor AP-2 alpha is preferentially cleaved by caspase 6 anddegraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells

      MOLECULAR AND CELLULAR BIOLOGY
    81. Chen, WS; Yu, YL; Lee, SF; Chiang, YJ; Chao, JR; Huang, JH; Chiong, JH; Huang, CJ; Lai, MZ; Yang-Yen, HF; Yen, JJY
      CREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal

      MOLECULAR AND CELLULAR BIOLOGY
    82. Wu, GJ; Varma, VA; Wu, MWH; Wang, SW; Qu, PP; Yang, HC; Petros, JA; Lim, SD; Amin, MB
      Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues

      PROSTATE
    83. Kortylewski, M; Heinrich, PC; Kauffmann, ME; Bohm, M; Mackiewicz, A; Behrmann, I
      Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cells

      BIOCHEMICAL JOURNAL
    84. Wang, YL; Devereux, W; Stewart, TM; Casero, RA
      Characterization of the interaction between the transcription factors human polyamine modulated factor (PMF-1) and NF-E2-related factor 2 (Nrf-2) in the transcriptional regulation of the spermidine/spermine N-1-acetyltransferase (SSAT) gene

      BIOCHEMICAL JOURNAL
    85. Olivares, C; Jimenez-Cervantes, C; Lozano, JA; Solano, F; Garcia-Borron, JC
      The 5,6-dihydroxyindole-2-carboxylic acid (DHICA) oxidase activity of human tyrosinase

      BIOCHEMICAL JOURNAL
    86. Berd, D
      Autologous, hapten-modified vaccine as a treatment for human cancers

      VACCINE
    87. Vinals, C; Gaulis, S; Coche, T
      Using in silico transcriptomics to search for tumor-associated antigens for immunotherapy

      VACCINE
    88. Hiraki, A; Ono, T; Tanaka, M; Kiura, K; Ueoka, H; Kawai, H; Harada, M; Nakayama, E; Noguchi, Y
      Generation of cytotoxic T lymphocytes against autologous lung cancer cellsresistant to apoptosis

      ANTICANCER RESEARCH
    89. Hildebrandt, T; Van Dijk, MCRF; Van Muijen, GNP; Weidle, UH
      Loss of heterozygosity of gene THW is frequently found in melanoma metastases

      ANTICANCER RESEARCH
    90. Wataya, H; Kamikawaji, N; Nakanishi, Y; Takayama, K; Hara, N; Sasazuki, T
      Quantitation of HLA-A*0201 bound tumor associated antigens on a peptide pulsed B cell line

      HUMAN IMMUNOLOGY
    91. Balazs, M; Adam, Z; Treszl, A; Begany, A; Hunyadi, J; Adany, R
      Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization

      CYTOMETRY
    92. Jain, RK
      Delivery of molecular and cellular medicine to solid tumors

      ADVANCED DRUG DELIVERY REVIEWS
    93. Jain, RK
      Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function

      JOURNAL OF CONTROLLED RELEASE
    94. Leszczyniecka, M; Roberts, T; Dent, P; Grant, S; Fisher, PB
      Differentiation therapy of human cancer: basic science and clinical applications

      PHARMACOLOGY & THERAPEUTICS
    95. Dye, JF; Jablenska, R; Donnelly, JL; Lawrence, L; Leach, L; Clark, P; Firth, JA
      Phenotype of the endothelium in the human term placenta

      PLACENTA
    96. Nie, Y; Yang, GY; Song, YL; Zhao, X; So, C; Liao, J; Wang, LD; Yang, CS
      DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas

      CARCINOGENESIS
    97. Garrido, F; Algarra, I
      MHC antigens and tumor escape from immune surveillance

      ADVANCES IN CANCER RESEARCH, VOL 83
    98. Sakamoto, A; Oda, Y; Itakura, E; Oshiro, Y; Tamiya, S; Honda, Y; Ishihara, A; Iwamoto, Y; Tsuneyoshi, M
      H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma

      HUMAN PATHOLOGY
    99. Sakai, N; Baba, M; Nagasima, Y; Kato, Y; Hirai, K; Kondo, K; Kobayashi, K; Yoshida, M; Kaneko, S; Kishida, T; Kawakami, S; Hosaka, M; Inayama, Y; Yao, M
      SPARC expression in primary human renal cell carcinoma: Upregulation of SPARC in sarcomatoid renal carcinoma

      HUMAN PATHOLOGY
    100. Masson, C; Menaa, F; Pinon-Lataillade, G; Frobert, Y; Radicella, JP; Angulo, JF
      Identification of KIN (KIN17), a human gene encoding a nuclear DNA-bindingprotein, as a novel component of the TP53-independent response to ionizingradiation

      RADIATION RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 01:11:42